Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069351 · ClinicalTrials.gov registry record · NA
Body Composition Changes During Overfeeding Plus Resistance Training
A NA study of Weight Gain and Resistance Training, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT04069351: Completed NA study of Weight Gain and Resistance Training, sponsored by Texas Tech University.
NCT04069351 is a NA study of Weight Gain and Resistance Training that has completed, run by Texas Tech University. The registered enrollment target is 32 participants, below the 221-participant average among 38 other Weight Gain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04069351, a NA study of Weight Gain and Resistance Training, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the relationship between the rate and composition of mass gain during overfeeding plus resistance training, investigate the validity of multiple assessment methods for quantifying body composition changes during this period, and evaluate the effects of subject presentation on the interpretation of body composition changes.
Primary Outcome
Calculated as change in fat-free mass (in kilograms) divided by change in body mass (in kilograms).
Conditions Studied
Interventions
- OTHER Resistance Training
- DIETARY_SUPPLEMENT High-calorie mass gainer supplement
Study Locations (1)
Texas
- Texas Tech University - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2019-11-26 |
| Phase | NA |
What the finished NCT04069351 record still lists
NCT04069351 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 221-participant average among 38 other Weight Gain trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Weight Gain appearing as the primary indexed condition, and to 2 interventions - of which Resistance Training is the first listed.
NCT04069351 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04069351 about?
NCT04069351 is a clinical study titled "Body Composition Changes During Overfeeding Plus Resistance Training". This study will examine the relationship between the rate and composition of mass gain during overfeeding plus resistance training, investigate the validity of multiple assessment methods for quantifying body composition changes during this period, and evaluate the effects of subject presentation on...
What is the current status of trial NCT04069351?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-09-18. Estimated completion is 2019-11-26.
What conditions does trial NCT04069351 study?
This clinical trial studies the following conditions: Weight Gain, Resistance Training, Overeating.
What interventions are being tested in trial NCT04069351?
The interventions under investigation include: Resistance Training (OTHER), High-calorie mass gainer supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04069351?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04069351 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Gain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04069351's enrollment target sits among peer trials
32 28th of 38 higher than 11 of 38 other Weight Gain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Gain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
RECRUITING · NA
-
Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial
RECRUITING · NA
-
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
RECRUITING · NA
-
Sleep and Metabolism
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI